(Q28239335)

https://api.crossref.org/works/10.1179%2F016164106X98080

Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna.

20 April 2017

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98080

P-selectin glycoprotein ligand 1 is not required for the development of experimental autoimmune encephalomyelitis in SJL and C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98080

The role of alpha-4 integrin in the aetiology of multiple sclerosis: current knowledge and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98080

Increased serum levels of soluble PECAM-1 in multiple sclerosis patients with brain gadolinium-enhancing lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98080

Elevated plasma endothelial microparticles in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98080

Serum from patients with multiple sclerosis downregulates occludin and VE-cadherin expression in cultured endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98080

Interferon (IFN)-beta 1a and IFN-beta 1b block IFN-gamma-induced disintegration of endothelial junction integrity and barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98080

Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98080

Endothelial cell class II major histocompatibility complex molecule expression in stereotactic brain biopsies of patients with acute inflammatory/demyelinating conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98080

Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98080

Gene and protein expression profiling of human cerebral endothelial cells activated with tumor necrosis factor-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98080

Matrix metalloproteinases and neuroinflammation in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98080

Differential mechanisms of action of interferon-beta and glatiramer aetate in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98080

Constitutive secretion of MMP9 by early-passage cultured human endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98080

Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98080

Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98080

The expression of microfilament-associated cell-cell contacts in brain endothelial cells is modified by IFN-beta1a (Rebif).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98080

Elevated endothelial microparticle-monocyte complexes induced by multiple sclerosis plasma and the inhibitory effects of interferon-beta 1b on release of endothelial microparticles, formation and transendothelial migration of monocyte-endothelial mi

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98080

Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98080

Monocyte-derived dendritic cells express and secrete matrix-degrading metalloproteinases and their inhibitors and are imbalanced in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F016164106X98080